Wednesday, June 10, 2026

pharma

Paxlovid

Paxlovid patent portfolio β€” 193 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

NEW YORK, NY, JP HQ
PMDA registrant Type
Company details
Status
Public
HQ
NEW YORK, NY, JP
Programs
0
Drugs
0
Patents
193
Intelligence Β· Patents

Paxlovid patents

193 pharmaceutical patents indexed for Paxlovid. 2 expire within 24 months.

Paxlovid has 193 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months β€” use filters for patent-cliff planning.

Patent portfolio

Page 5 of 5
  1. US 6090368

    Pharmaceutical compositions for intranasal spray administration of ketorolac tromethamine

    Expires Mon Jul 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Paxlovid have?

193 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Paxlovid patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.